These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14702926)

  • 1. Overview of chemotherapy-induced diarrhea.
    Viele CS
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 3):2-5. PubMed ID: 14702926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of radiation- and chemoradiation-induced diarrhea.
    Gwede CK
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 3):6-10. PubMed ID: 14702927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of acute cancer treatment-induced diarrhea.
    Stern J; Ippoliti C
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 3):11-6. PubMed ID: 14702928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategies for the prevention and reduction of cancer treatment-induced diarrhea.
    Anthony L
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 3):17-21. PubMed ID: 14702929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of chemotherapy induced diarrhea].
    Schultz M; Schölmerich J; Kullmann F
    Z Gastroenterol; 2004 Jun; 42(6):527-38. PubMed ID: 15190449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.
    Hoff PM; Saragiotto DF; Barrios CH; del Giglio A; Coutinho AK; Andrade AC; Dutra C; Forones NM; Correa M; Portella Mdo S; Passos VQ; Chinen RN; van Eyll B
    J Clin Oncol; 2014 Apr; 32(10):1006-11. PubMed ID: 24516038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommended guidelines for the treatment of chemotherapy-induced diarrhea.
    Wadler S; Benson AB; Engelking C; Catalano R; Field M; Kornblau SM; Mitchell E; Rubin J; Trotta P; Vokes E
    J Clin Oncol; 1998 Sep; 16(9):3169-78. PubMed ID: 9738589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.
    Keefe DM; Elting LS; Nguyen HT; Grunberg SM; Aprile G; Bonaventura A; Selva-Nayagam S; Barsevick A; Koczwara B; Sonis ST
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):675-80. PubMed ID: 25055935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Pestalozzi BC
    N Engl J Med; 2001 Jan; 344(4):306; author reply 306-7. PubMed ID: 11191662
    [No Abstract]   [Full Text] [Related]  

  • 10. The nurse's role in diarrhea management.
    Hogan CM
    Oncol Nurs Forum; 1998 Jun; 25(5):879-86. PubMed ID: 9644704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-related cognitive dysfunction in breast cancer.
    O'Shaughnessy J
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 2):17-24. PubMed ID: 14702917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for the development of irinotecan-related cholinergic syndrome using ordered logistic regression analysis.
    Kanbayashi Y; Ishikawa T; Kanazawa M; Nakajima Y; Tabuchi Y; Kawano R; Yoshioka T; Yoshida N; Hosokawa T; Takayama K; Taguchi T
    Med Oncol; 2018 Apr; 35(6):82. PubMed ID: 29705823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of irinotecan-induced diarrhea by octreotide after loperamide failure.
    Barbounis V; Koumakis G; Vassilomanolakis M; Demiri M; Efremidis AP
    Support Care Cancer; 2001 Jun; 9(4):258-60. PubMed ID: 11430421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application and recent research progress of irinotecan in treatment of advanced colorectal cancer].
    Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):718-9. PubMed ID: 17274384
    [No Abstract]   [Full Text] [Related]  

  • 15. Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study.
    Pastorino A; Di Bartolomeo M; Maiello E; Iaffaioli V; Ciuffreda L; Fasola G; Di Costanzo F; Frassineti GL; Marchetti P; Antoniotti C; Leone F; Zaniboni A; Aprile G; Zilocchi C; Sobrero A; Bordonaro R
    Clin Colorectal Cancer; 2018 Sep; 17(3):e457-e470. PubMed ID: 29605592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics and oncology nursing.
    Calzone KA; Masny A
    Semin Oncol Nurs; 2004 Aug; 20(3):178-85. PubMed ID: 15491027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of chemotherapy-induced mucositis and diarrhea].
    Kandabashi K; Sasaki T
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):24-8. PubMed ID: 16410693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-based discussion for the management of metastatic colorectal cancer.
    Biedrzycki BA
    ONS News; 2006; 21(8 Suppl):31-2. PubMed ID: 16925141
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical implications of chemotherapy-induced diarrhea in patients with cancer.
    Arnold RJ; Gabrail N; Raut M; Kim R; Sung JC; Zhou Y
    J Support Oncol; 2005; 3(3):227-32. PubMed ID: 15915825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer.
    Punt CJ; Koopman M
    J Clin Oncol; 2008 Apr; 26(11):1907-8; author reply 1908-9. PubMed ID: 18398161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.